Inventiva S.A.
IVA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001756594
No open-market purchases or sales by Inventiva S.A. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $319.5M in total; no superinvestor holds it.
Other share classesIVEVF
13F holders, Q4 2025
Institutional positions in Inventiva S.A. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 53
- +38 vs. Q3 2025
- Shares held
- 46.7M
- +41.6M (+814.7%) vs. Q3 2025
- Total value
- $217.2M
- +$187.8M (+638.3%) vs. Q3 2025
- New holders
- 38
- 6 more added
- Sold out
- 0
- 1 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 88 | $319.5M |
| Q1 2026 | 65 | $290.4M |
| Q4 2025 | 53 | $217.2M |
| Q3 2025 | 15 | $29.4M |
| Q2 2025 | 12 | $15.7M |
| Q1 2025 | 8 | $12.2M |
| Q4 2024 | 7 | $11.7M |
| Q3 2024 | 7 | $9.06M |
| Q2 2024 | 7 | $14.5M |
| Q1 2024 | 8 | $17.6M |
| Q4 2023 | 9 | $21.9M |
| Q3 2023 | 8 | $20.6M |
| Q2 2023 | 9 | $19.5M |
| Q1 2023 | 9 | $18.3M |
| Q4 2022 | 7 | $21.9M |
| Q3 2022 | 8 | $33.1M |
| Q2 2022 | 10 | $51.8M |
| Q1 2022 | 10 | $45.0M |
| Q4 2021 | 10 | $51.3M |
| Q3 2021 | 12 | $52.5M |
| Q2 2021 | 14 | $21.3M |
| Q1 2021 | 13 | $23.8M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Inventiva S.A.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 1 | $5 | 0.00% | +1 | New |
| Bank of America Corp | 44 | $205 | 0.00% | +44 | New |
| Atlantic Union Bankshares Corp | 300 | $1.40K | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 402 | $2.00K | 0.00% | 00.0% | Unchanged |
| GAMMA Investing LLC | 1,780 | $8.28K | 0.00% | +1,780 | New |
| Rhumbline Advisers | 2,632 | $12.2K | 0.00% | +2,482+1,654.7% | Added |
| AQR Capital Management LLC | 10,000 | $46.5K | 0.00% | 00.0% | Unchanged |
| Creative Planning | 10,000 | $46.5K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 12,869 | $60.0K | 0.00% | +12,869 | New |
| Citadel Advisors LLC | 14,699 | $68.3K | 0.00% | +14,699 | New |
| XTX Topco Ltd | 18,053 | $83.9K | 0.00% | +18,053 | New |
| GWM Advisors LLC | 20,000 | $93.0K | 0.00% | 00.0% | Unchanged |
| Cerity Partners LLC | 20,000 | $93.0K | 0.00% | +20,000 | New |
| Wealth Enhancement Advisory Services, LLC | 25,770 | $117.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 57,417 | $267.0K | 0.00% | +57,417 | New |
| Quadrature Capital Ltd | 66,929 | $311.2K | 0.00% | +66,929 | New |
| Commonwealth Equity Services, LLC | 77,561 | $360.7K | 0.00% | +12,704+19.6% | Added |
| Superstring Capital Management LP | 100,000 | $465.0K | 0.25% | +100,000 | New |
| Persistent Asset Partners Ltd | 129,711 | $603.2K | 0.29% | +129,711 | New |
| Marshall Wace, LLP | 172,093 | $800.2K | 0.00% | +172,093 | New |
| Eventide Asset Management, LLC | 250,000 | $1.16M | 0.02% | +250,000 | New |
| Yiheng Capital Management, L.P. | 255,915 | $1.19M | 0.52% | −2,389,011−90.3% | Reduced |
| Saturn V Capital Management LLC | 283,166 | $1.32M | 0.24% | +283,166 | New |
| Squadron Capital Management LLC | 300,000 | $1.40M | 0.62% | +300,000 | New |
| Diadema Partners LP | 334,251 | $1.55M | 0.93% | +334,251 | New |
| Simplify Asset Management Inc. | 337,662 | $1.57M | 0.03% | +337,662 | New |
| Goldman Sachs Group Inc | 429,595 | $2.00M | 0.00% | +429,595 | New |
| StemPoint Capital LP | 467,242 | $2.17M | 0.37% | +436,418+1,415.8% | Added |
| Deep Track Capital, LP | 490,000 | $2.28M | 0.05% | +490,000 | New |
| Alyeska Investment Group, L.P. | 500,000 | $2.33M | 0.01% | +500,000 | New |
| Ikarian Capital, LLC | 502,601 | $2.33M | 0.30% | +502,601 | New |
| Morgan Stanley | 507,701 | $2.36M | 0.00% | +477,921+1,604.8% | Added |
| J. Goldman & Co LP | 516,445 | $2.40M | 0.09% | +516,445 | New |
| Ameriprise Financial Inc | 615,473 | $2.86M | 0.00% | +615,473 | New |
| Boothbay Fund Management, LLC | 658,971 | $3.06M | 0.08% | +658,971 | New |
| BVF Inc | 686,040 | $3.19M | 0.11% | 00.0% | Unchanged |
| Propel Bio Management, LLC | 1,000,000 | $4.65M | 3.97% | +1,000,000 | New |
| RTW Investments, LP | 1,298,701 | $6.04M | 0.06% | +1,298,701 | New |
| NEXTBio Capital Management LP | 1,298,701 | $6.04M | 3.54% | +1,298,701 | New |
| NEA Management Company, LLC | 1,462,586 | $6.80M | 0.35% | 00.0% | Unchanged |
| Fan Yu | 1,500,000 | $6.97M | 7.56% | +1,500,000 | New |
| Ally Bridge Group (NY) LLC | 1,500,000 | $6.97M | 11.07% | +1,500,000 | New |
| Andera Partners | 1,818,181 | $8.45M | 4.79% | +1,818,181 | New |
| Polar Capital Holdings Plc | 1,998,880 | $9.29M | 0.04% | +1,998,880 | New |
| Caligan Partners LP | 2,000,000 | $9.30M | 0.85% | +2,000,000 | New |
| Franklin Resources Inc | 2,500,141 | $11.6M | 0.00% | +2,500,141 | New |
| SymBiosis Capital Partners, LLC | 2,600,000 | $12.1M | 11.04% | +2,600,000 | New |
| UBS Group AG | 2,643,702 | $12.3M | 0.00% | +2,634,580+28,881.6% | Added |
| Millennium Management LLC | 2,652,570 | $12.3M | 0.01% | +2,540,540+2,267.7% | Added |
| Trails Edge Capital Partners, LP | 2,657,997 | $12.4M | 3.05% | +2,657,997 | New |
| ADAR1 Capital Management, LLC | 2,709,846 | $12.6M | 0.94% | +2,709,846 | New |
| Paradigm Biocapital Advisors LP | 4,000,000 | $18.6M | 0.50% | +4,000,000 | New |
| Samsara BioCapital, LLC | 5,194,805 | $24.2M | 2.49% | +5,194,805 | New |